Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, June 19, 2015 3:46:57 PM
bullish
## source: finance.yahoo.com
Thu, 18 Jun 2015 11:25:10 GMT ~ UPDATE -- TRACON Pharmaceuticals to Present at the JMP Securities Life Science Conference
[GlobeNewswire] - SAN DIEGO -- In a release issued yesterday by TRACON Pharmaceuticals , the date and time of the conference have been updated to 3:30 pm EDT on Tuesday, June 23, 2015.
read full: http://finance.yahoo.com/news/tracon-pharmaceuticals-present-jmp-securities-112510196.html
*********************************************************
Wed, 17 Jun 2015 20:05:00 GMT ~ TRACON Pharmaceuticals to Present at the JMP Securities Life Science Conference
[GlobeNewswire] - SAN DIEGO -- TRACON Pharmaceuticals , a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration ...
read full: http://finance.yahoo.com/news/tracon-pharmaceuticals-present-jmp-securities-200500595.html
*********************************************************
Mon, 01 Jun 2015 12:55:00 GMT ~ TRACON Pharmaceuticals Announces Positive Results of TRC105 Clinical Trials in Sarcoma and Liver Cancer at the American Society of Clinical Oncology (ASCO) 2015 Annual Meeting
[GlobeNewswire] - Complete responses observed in two patients with angiosarcoma in TRC105 + Votrient sarcoma study
read full: http://finance.yahoo.com/news/tracon-pharmaceuticals-announces-positive-results-125500509.html
*********************************************************
Fri, 22 May 2015 17:04:45 GMT ~ TRACON PHARMACEUTICALS, INC. Financials
read full: http://finance.yahoo.com/q/is?s=tcon
*********************************************************
Thu, 14 May 2015 20:05:00 GMT ~ TRACON's TRC105 Receives FDA Fast Track Designation
[GlobeNewswire] - SAN DIEGO -- TRACON Pharmaceuticals , a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration ...
read full: http://finance.yahoo.com/news/tracons-trc105-receives-fda-fast-200500755.html
*********************************************************
$TCON charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TCON company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TCON/company-info
Ticker: $TCON
OTC Market Place: Not Available
CIK code: not found
Company name: TRACON Pharmaceuticals, Inc.
Incorporated In:
$TCON share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$TCON extra dd links
Company name: TRACON Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TCON/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TCON/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TCON+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TCON+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TCON+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TCON/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TCON/news - http://finance.yahoo.com/q/h?s=TCON+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TCON/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TCON/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TCON/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TCON/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TCON/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TCON/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TCON/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TCON/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TCON+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TCON
DTCC (dtcc.com): http://search2.dtcc.com/?q=TRACON+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=TRACON+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=TRACON+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TCON/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TCON
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TCON/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TCON/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TCON/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TCON/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TCON/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TCON/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TCON/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TCON&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TCON
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TCON/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TCON+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TCON+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TCON
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TCON
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TCON+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TCON/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TCON+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TCON.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TCON
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TCON/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TCON/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TCON/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TCON/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TCON
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TCON
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TCON:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TCON
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TCON
$TCON DD Notes ~ http://www.ddnotesmaker.com/TCON
Recent TCON News
- TRACON Pharmaceuticals Announces it Will Wind Down Operations • GlobeNewswire Inc. • 07/30/2024 08:44:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 01:00:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 09:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:05:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 09:00:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 12:00:12 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/07/2024 10:03:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:00:35 PM
- TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024 • GlobeNewswire Inc. • 02/28/2024 09:02:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:31:59 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 10:00:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 01:05:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 09:00:09 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM